Wakefield Asset Management’s Gilead Sciences GILD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.3M	Sell	30,860 -109	-0.4%	-$15.3K	1.14%	21
2025 Q4	$3.8M	Sell	30,969 -377	-1%	-$45.8K	1.03%	33
2025 Q3	$3.48M	Sell	31,346 -2,422	-7%	-$275K	0.95%	35
2025 Q2	$3.74M	Sell	33,768 -813	-2%	-$86.5K	1.05%	27
2025 Q1	$3.87M	Buy	34,581 +29,020	+522%	+$2.99M	1.17%	15
2024 Q4	$514K	Buy	+5,561	New	+$501K	0.17%	131
2023 Q2	–	Sell	-34,548	Closed	-$2.87M	–	164
2023 Q1	$2.87M	Buy	34,548 +180	+0.5%	+$14.9K	1.19%	22
2022 Q4	$2.95M	Buy	34,368 +29,099	+552%	+$2.3M	1.25%	18
2022 Q3	$325K	Sell	5,269 -62	-1%	-$3.91K	0.15%	135
2022 Q2	$330K	Buy	+5,331	New	+$330K	0.14%	138
2019 Q4	–	Sell	-3,181	Closed	-$202K	–	170
2019 Q3	$202K	Sell	3,181 -95	-3%	-$6.21K	0.09%	147
2019 Q2	$221K	Buy	+3,276	New	+$216K	0.09%	145